Wealthfront’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$1.7M Buy
6,943
+341
+5% +$78.4K 0.02% 149
2018
Q2
$1.37M Sell
6,602
-617
-9% -$131K 0.01% 184
2018
Q1
$1.49M Buy
7,219
+1,199
+20% +$252K 0.02% 177
2017
Q4
$1.14M Buy
6,020
+146
+2% +$28K 0.01% 204
2017
Q3
$1.11M Sell
5,874
-89
-1% -$16.1K 0.01% 177
2017
Q2
$1.04M Buy
5,963
+1,234
+26% +$207K 0.02% 148
2017
Q1
$726K Buy
4,729
+509
+12% +$77.8K 0.01% 166
2016
Q4
$595K Sell
4,220
-673
-14% -$99.2K 0.01% 167
2016
Q3
$778K Buy
4,893
+231
+5% +$35.6K 0.02% 133
2016
Q2
$689K Buy
4,662
+1,411
+43% +$208K 0.02% 131
2016
Q1
$460K Sell
3,251
-1,816
-36% -$243K 0.01% 164
2015
Q4
$719K Buy
5,067
+2,344
+86% +$313K 0.03% 104
2015
Q3
$333K Buy
2,723
+649
+31% +$84.6K 0.01% 181
2015
Q2
$269K Buy
2,074
+629
+44% +$82K 0.01% 207
2015
Q1
$194K Buy
1,445
+626
+76% +$80.7K 0.01% 251
2014
Q4
$103K Sell
819
-1,684
-67% -$205K 0.01% 348
2014
Q3
$305K Buy
2,503
+944
+61% +$115K 0.02% 92
2014
Q2
$187K Buy
1,559
+522
+50% +$61.4K 0.02% 119
2014
Q1
$126K Buy
+1,037
New +$123K 0.02% 99

Other funds holding TMO

Wealthfront's TMO Position: Q3 2018 in Review

Wealthfront increased its Thermo Fisher Scientific (TMO) stake by 5.2% in Q3 2018, buying an estimated $78.4K and bringing the position to 6,943 shares worth $1.7M. The position accounts for 0.02% of the portfolio, ranked #149.

Wealthfront first reported a position in TMO in Q1 2014 and has held it in 19 quarters since. 1,351 funds tracked by Wall St. Rank hold TMO as of Q3 2018.

  • Wealthfront held 6,943 shares of Thermo Fisher Scientific worth $1.7M as of Q3 2018.
  • Wealthfront bought 341 Thermo Fisher Scientific shares in Q3 2018, an estimated $78.4K.
  • Thermo Fisher Scientific made up 0.02% of Wealthfront's portfolio in Q3 2018, its #149 holding.
  • Wealthfront first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 19 quarters since.
  • 1,351 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2018.

Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.